These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 971555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ, Boyd GW, Peart WS.
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [Abstract] [Full Text] [Related]

  • 3. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of the renin-angiotensin system in dogs with perinephritis hypertension.
    Johnson JA, Stubbs D, Keitzer WF.
    Proc Soc Exp Biol Med; 1976 Sep; 152(4):560-4. PubMed ID: 967886
    [Abstract] [Full Text] [Related]

  • 6. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH, Dalakos TG, Anderson GH.
    Prog Biochem Pharmacol; 1976 Sep; 12():214-26. PubMed ID: 1019165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Pharmacol; 1977 Aug 17; 12(1):1-5. PubMed ID: 902672
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH, Bönner G, Gram N, Mann JF, Helber A, Ganten D.
    Klin Wochenschr; 1978 Aug 17; 56 Suppl 1():97-105. PubMed ID: 732257
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M, Fiorentini R, Onesti G, Bellini G, Gould AB, Hessan H, Kim KE, Swartz C.
    Clin Sci Mol Med; 1978 Jun 17; 54(6):633-7. PubMed ID: 657733
    [Abstract] [Full Text] [Related]

  • 13. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977 Jun 17; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 14. Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.
    Thurston H, Swales JD.
    Clin Sci Mol Med; 1977 Mar 17; 52(3):299-304. PubMed ID: 844262
    [Abstract] [Full Text] [Related]

  • 15. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov 17; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Aust N Z J Med; 1976 Aug 17; 6(3 Suppl):48-52. PubMed ID: 1071403
    [Abstract] [Full Text] [Related]

  • 19. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Invest; 1977 Dec 17; 7(6):473-9. PubMed ID: 415868
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.